Julie M Gastier-Foster

7PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Medical biotechnology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.

Florette K Hazard, Angus M S Toland, Serena Y Tan

|May 08, 2025
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.

Nicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval

|Oct 27, 2023
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.

Karen R Rabin, Meenakshi Devidas, Zhiguo Chen

|Jul 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

Meredith S Irwin, Arlene Naranjo, Fan F Zhang

Pageof 2